Authors:
Gilchrist, IC
O'Shea, JC
Kosoglou, T
Jennings, LK
Lorenz, TJ
Kitt, MM
Kleiman, NS
Talley, D
Aguirre, F
Davidson, C
Runyon, J
Tcheng, JE
Citation: Ic. Gilchrist et al., Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention, CIRCULATION, 104(4), 2001, pp. 406-411
Authors:
Tcheng, JE
Talley, JD
O'Shea, JC
Gilchrist, IC
Kleiman, NS
Grines, CL
Davidson, CJ
Lincoff, AM
Califf, RM
Jennings, LK
Kitt, MM
Lorenz, TJ
Citation: Je. Tcheng et al., Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study), AM J CARD, 88(10), 2001, pp. 1097-1102
Authors:
Hopper, KD
Gilchrist, IC
Landis, JR
Localio, AR
Wilson, RP
Pae, WE
Kunselman, AR
Griffith, JW
Pierce, WS
Potok, PS
TenHave, TR
Citation: Kd. Hopper et al., Detection of Bjork-Shiley convexo-concave heart valve outlet strut single leg separations: Consensus image acquisition and interpretation using two different cineradiographic imaging technologies, CARDIOLOGY, 91(2), 1999, pp. 96-101
Authors:
Gilchrist, IC
Gardner, LH
Muhlestein, JB
Arnold, AM
Lincoff, AM
Califf, RM
Tcheng, JE
Topol, EJ
Citation: Ic. Gilchrist et al., Effect of institutional volume and academic status on outcomes of coronaryinterventions: The IMPACT-II experience, AM HEART J, 138(5), 1999, pp. 976-982